{
  "variant_id": {
    "Gene": "PIK3CA",
    "Protein_Change": {
      "ref": "H",
      "alt": "Y",
      "position": "1047"
    },
    "variant_string_id": "PIK3CA H1047Y"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The PIK3CA gene encodes the p110Î± subunit of phosphatidylinositol-4,5-bisphosphate 3 kinase (PI3K), which is involved in cell growth, proliferation, and survival. Mutations in this gene are commonly associated with cancer due to its role in downstream signaling pathways such as the AKT/mTOR pathway.",
      "judgment": "Yes",
      "reasoning": "The paper clearly defines the disease mechanism involving PIK3CA mutations in cancer pathogenesis."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The study uses an enzyme activity assay to assess the kinase activity of PIK3CA mutants and a protein interaction assay to evaluate downstream signaling pathway activation.",
      "judgment": "Yes",
      "reasoning": "These assays effectively model the disease pathogenesis by directly assessing the functional impact of the mutation on PI3K signaling."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "sub_step_name": "Sub-step 3a: Basic Controls and Replicates",
      "extracted_paper_info": "The study includes both wild-type and known pathogenic PIK3CA mutants as controls. The experiments were performed in triplicate, and the results are consistent across replicates.",
      "judgment": "Yes",
      "reasoning": "Basic controls (wild-type and known pathogenic variants) and multiple replicates were included, indicating a robust experimental design."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_step_name": "Sub-step 4a: Statistical Analyses",
      "extracted_paper_info": "Statistical analyses include ANOVA with Tukey's post hoc test, and p-values < 0.05 are considered significant.",
      "judgment": "Yes",
      "reasoning": "The statistical methods used are sufficient to assess the functional impact of the variant."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "sub_step_name": "Sub-step 4c: Correlate OddsPath",
      "extracted_paper_info": "The study does not explicitly report OddsPath values but provides sufficient statistical support for the functional impact of H1047Y.",
      "judgment": "Yes",
      "reasoning": "Based on the robust experimental design and statistical analysis, the functional evidence supports a moderate level of pathogenicity."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_moderate"
  },
  "overall_conclusion": "The H1047Y variant in PIK3CA shows moderate supporting evidence for pathogenicity based on its functional impact on kinase activity and downstream signaling pathway activation, as demonstrated by the enzyme activity assay and protein interaction studies."
}